Tofacitinib for the Treatment of Pouch-Related Disorders: A Case Series

Inflamm Bowel Dis. 2022 Nov 2;28(11):1787-1789. doi: 10.1093/ibd/izac147.
No abstract available

Keywords: colectomy; cuffitis; inflammatory bowel disease; pouch; pouchitis; ulcerative colitis.

Plain language summary

In this case series, 6 patients with chronic pouchitis (n = 3), cuffitis (n = 2), or Crohn’s-like disease of the pouch (n = 1) were treated with tofacitinib. One patient achieved clinical response; however, all patients ultimately discontinued therapy due to nonresponse or adverse events.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colitis, Ulcerative* / surgery
  • Colonic Pouches*
  • Humans
  • Piperidines
  • Pouchitis* / therapy
  • Proctocolectomy, Restorative*
  • Pyrimidines

Substances

  • tofacitinib
  • Piperidines
  • Pyrimidines